Tobira Therapeutics' Reverse Merger Round

Tobira Therapeutics raised a round of funding on May 05, 2015. Investors include Regado Biosciences.

Tobira is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapies to treat liver disease, inflammation, fibrosis and HIV. The company's lead product, c…

Articles about Tobira Therapeutics' Reverse Merger Round: